Technology companies are developing a wide array of healthcare products and services that get deployed in hospitals and homes. Few are focused on what happens in between—the ride to and from medical appointments. Circulation is one of the tech businesses trying to make non-emergency medical transportation more effective and efficient. The company’s software coordinates rides […]
NYS Entity Status
NYS Filing Date
APRIL 26, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - KLINGER MEDICAL PRODUCTS CORP.
AROUND THE WEB
- Investors Pump $10.5M Into Circulation for Medical Transport Software
By Jeff Engel - Tuesday Jul 25, 2017
- Near The East River, Plans Emerge For NY’s Next Life Science Center
By Ben Fidler - Monday Aug 21, 2017
At a time when biotech incubators and shared spaces are beginning to multiply in Manhattan, work on what could rank among the city’s largest biotech centers—if it can all come together—is just getting underway. According to Paul Wexler, a longtime healthcare-focused real estate broker, construction should begin next year on what is being called the […]
- Medical College of Wisconsin Receives $37.8 Million From Kern Family
By email@example.com (Kyoko Uchida) - Monday Jun 12, 2017
The Robert D. and Patricia E. Kern Institute for the Transformation of Medical Education will lead a national movement to transform medical education...
- Marine Corps Plane Crash: The Victims
By THE NEW YORK TIMES - Thursday Jul 13, 2017
Family members and friends have begun identifying many of the 16 American service members who died on Monday when their plane crashed in rural Mississippi.
- John M. Belk Endowment Awards $10 Million to College Advising Corps
By firstname.lastname@example.org (Kyoko Uchida) - Monday Jul 17, 2017
The gift will support existing partnerships with colleges in North Carolina aimed at boosting postsecondary educational attainment in the state....
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]